How Rapid Results Protect Your Star Rating
NIGHTHAWK PROTOCOL™ delivers results the same day we receive the specimen.
NIGHTHAWK VERIFY™ monitors specimen temperature from your facility to our lab.
We know if it ever reaches 77°F and how long it was at or above 77°F.
Infection control and antibiotic stewardship are the top two survey citations in Skilled Nursing Facilities (SNFs). Every hour your team waits for lab results is an hour of empiric treatment, incomplete documentation, and risk to your CMS rating.
Specimen Temperature Monitoring
How Diagnostic Delays Feed Into Lower Star Ratings — and How BDL Helps Reverse the Trend
Your star rating is calculated from three domains: health inspections, staffing, and quality measures. Slow diagnostic turnaround creates problems in all three — but the damage is most direct in health inspections and quality measures. Here is where rapid results change the equation.
Antibiotic Stewardship: Documentation That Surveyors Actually Want to See
CMS requires every SNF to maintain an antibiotic stewardship program with protocols and monitoring.9 Surveyors review whether antibiotic orders include documented indication, dose, duration, and clinical rationale. When results arrive a day or two after the antibiotic was started, the documentation trail shows empiric prescribing followed by a late correction.
With organism identification and resistance-gene data in hand within hours, your prescribers can document targeted treatment from the initial order. MRSA PCR wound swabs carry a 98.4% negative predictive value14 — giving your team the confidence to de-escalate from broad-spectrum antibiotics with the kind of documentation surveyors want to see.
Health Inspections: Faster and More Accurate Infection Detection
Infection control noncompliance (F-880) was the #1 deficiency citation in FY 2025, flagged at 42% of facilities surveyed.7 Surveyors evaluate whether your facility identifies infections promptly, initiates appropriate treatment, and documents the clinical rationale. When results take a day or more, your team is treating empirically — and documenting empirically. That gap is exactly what surveyors cite.
Results the same day we receive the specimen mean your nursing staff can document organism-specific identification and targeted treatment decisions that same day. PCR detects approximately 30% more clinically significant pathogens than culture alone10 — including anaerobes and resistance genes that traditional methods miss entirely. When the surveyor pulls the chart, the clinical rationale is already there.
Quality Measures: Reduce Hospital Readmissions
The SNF Value-Based Purchasing Program ties incentive payments directly to readmission prevention. When a wound infection or respiratory case escalates because the pathogen was not identified quickly enough, the result is often a hospital transfer. That transfer counts against your quality measures and your VBP score — and stays in the data for years.8
PCR-guided treatment achieves clinical success rates of 88% compared to 78% for culture-guided treatment.13 Faster pathogen identification means earlier targeted intervention — reducing the escalations that lead to hospital transfers and readmission penalties.
What Your Facility Receives Now vs. What Is Possible
Most SNFs rely on one of two diagnostic pathways. Traditional culture and sensitivity testing, which has been the standard for decades, takes 3 to 7 days for final results and frequently misses fastidious, anaerobic, and polymicrobial organisms.10,11 The trend is that SNFs are quickly moving to PCR-based molecular testing. But most labs serving this market deliver results in 24 to 48 hours.12
Neither timeline serves your DON, your wound care team, or your star rating well. Research demonstrates that PCR-guided treatment achieves clinical success rates of 88% compared to 78% for culture-guided treatment in wound infections.13 PCR detects approximately 30% more clinically significant pathogens than culture alone, including resistance genes that inform antibiotic selection.10
| Diagnostic Method | Turnaround Time | Clinical Impact |
|---|---|---|
| Traditional Culture & Sensitivity | 3–7 days | Empiric treatment for days; misses anaerobes and polymicrobial infections |
| Competitor PCR Labs | 24–48 hours | Faster than culture but still delays targeted treatment by a full day or more |
| BDL — NIGHTHAWK PROTOCOL™ & NIGHTHAWK VERIFY™ | Results the same day we receive the specimen | Targeted treatment can begin the same day we receive the specimen |
MRSA PCR wound swab testing demonstrates a negative predictive value of 98.4%, enabling rapid and confident de-escalation from broad-spectrum antibiotics to targeted therapy.14 That de-escalation is precisely what CMS surveyors want to see documented in your antibiotic stewardship records.
Results the Same Day We Receive the Specimen. Every Test. Every Time.
BDL's NIGHTHAWK PROTOCOL™ and NIGHTHAWK VERIFY™ were built for facilities where diagnostic speed is not a convenience — it is a clinical and regulatory necessity. Specimens picked up in the afternoon are processed and you will receive results the same day we receive the specimen, via secure electronic LIS portal. A real person answers the phone 24/7. Our 24-hour team monitors every shipment overnight.
NIGHTHAWK VERIFY™
The temperature of every specimen tracked from your facility to our lab. We know if it ever reached 77°F. and for how long.
VERIFY™
Every specimen shipped to our lab includes a proprietary high technology sensor, the device behind NIGHTHAWK VERIFY™. This compact sensor is placed inside every specimen container and monitors temperature throughout transport. If the sample ever reaches 77°F, the sensor records the cumulative duration of all breaches, giving our laboratory team measurable, visual proof of exactly how long specimen integrity was compromised.
When the specimen arrives at our lab, we know before testing begins. No guesswork. No assumptions.
BDL offers four PCR tests directly relevant to the conditions that drive infection control citations, readmissions, and antibiotic stewardship documentation in SNFs:
Wound Care PCR — Identifies organisms and antibiotic resistance genes across superficial, deep, and non-healing wounds. Covers MRSA, Pseudomonas aeruginosa, Streptococcus species, anaerobes, and fungal pathogens that culture frequently misses.
Respiratory PCR — Identifies viral and bacterial respiratory pathogens across five specialized tests covering extended viral, treatable viruses, pharyngitis, bronchitis, and measles organisms.
Genitourinary Infection PCR — Targets organisms responsible for complicated urinary and genital infections common in the long-term care population.
UTI PCR — Two test options for standard urinary tract infections and expanded testing for high-risk populations, with resistance gene profiling.
For Wound Care Companies Serving SNFs
If you provide wound care services to SNFs, your clinical outcomes are tied to the diagnostic speed of the lab behind you. Most PCR labs serving this market deliver results in 24 to 48 hours. That means your clinicians are still making treatment decisions without organism-level data for an entire day or more after the specimen ships. BDL delivers results the same day we receive the specimen, giving your team pathogen identification and resistance-gene data before the next dressing change — improving your outcomes, strengthening your value proposition to facilities, and supporting the documentation trail that protects both your client's star rating and your clinical reputation.
Protect Your Stars. Protect Your Facility.
Find out how BDL's NIGHTHAWK PROTOCOL™ and NIGHTHAWK VERIFY™ can strengthen your infection control documentation, support your antibiotic stewardship program, and help safeguard your CMS star rating.
Contact Us(800) 897-1773 | A Real Person Answers 24/7
care@bdlusa.com | A Real Person Responds to Emails 24/7
References
- ExaCare. "SNF Star Ratings: Improving Your Quality Rankings." 2025. Hospitals and ACOs rely on CMS ratings when selecting discharge partners; some regions enforce minimum star rating thresholds for preferred provider networks.
- Kaiser Family Foundation. "Reading the Stars: Nursing Home Quality Star Ratings, Nationally and by State." Analysis of Nursing Home Compare data. More than one-third of nursing homes have overall ratings of 1 or 2 stars; for-profit facilities tend to have lower ratings than non-profit facilities.
- PMC / National Institutes of Health. "Medicare skilled nursing facilities' occupancy and payer source." BMC Health Services Research, 2024. Medicare Advantage, covering >30% of Medicare NH residents, increasingly contracts selectively with higher-quality providers.
- GreenField Health & Rehabilitation / StarPRO. "The Growing Importance of Nursing Home 5-Star Ratings & Survey Impact." 2020. CMS waiver of 3-day stay requires ≥3-star partners; HUD and institutional investors incorporate star ratings in lending risk assessments.
- StarPRO / CliftonLarsonAllen. "SNF Trends Report Underlines Correlation Between Star Ratings, Occupancy and Operating Margin." 2020 SNF Cost Comparison and Industry Trends Report. Only 4- and 5-star facilities exceed national median occupancy.
- Aria Care Partners. "Skilled Nursing Facility and Post-Acute Care 2025 Trends." In 2023, 36% of SNFs had operating margins of -4.0% or worse; 34% at 4% or better.
- McKnight's Long-Term Care News. "Feds remove infection control surveys from standard inspections." August 2025. In FY 2025, F-880 infection control deficiency was cited at 42% of nursing homes surveyed, making it the #1 citation.
- CMS. Skilled Nursing Facility Value-Based Purchasing Program. FY 2025 performance centered on all-cause hospital readmission measure. Facilities excelling in readmission prevention maximize incentive payments.
- Centers for Medicare and Medicaid Services. Requirements of Participation for Long-Term Care Facilities, 42 CFR §483.80. Facilities must maintain antibiotic stewardship programs with use protocols and monitoring systems. CDC Core Elements of Antibiotic Stewardship for Nursing Homes, updated September 2025.
- Microbiology Spectrum (ASM). "Comparative diagnostic evaluation of real-time PCR and culture for detecting pathogens in podiatric wound infections." 2025. PCR sensitivity 98.3%; detected approximately 30% more clinically significant pathogens than culture, including anaerobes and resistance genes.
- PubMed (PMID: 21077984). "Real-time PCR assays compared to culture-based approaches for identification of aerobic bacteria in chronic wounds." PCR assay sensitivity of 100% (quantitative culture reference); turnaround time as short as 4–6 hours vs. days for culture.
- Industry analysis of commercial PCR laboratory advertised turnaround times for SNF clients. Standard advertised range: 24–48 hours from receipt of the specimen. BDL NIGHTHAWK PROTOCOL™: results the same day we receive the specimen.
- Dowd SE et al. "Molecular diagnostics and personalised medicine in wound care: assessment of outcomes." Journal of Wound Care. PCR-guided treatment achieved 88% clinical success vs. 78% for culture-guided treatment.
- Diagnostic Microbiology and Infectious Disease / ScienceDirect. "Correlation of MRSA polymerase chain reaction (PCR) wound swab testing and wound cultures in skin and soft tissue infections." 2021–2022. MRSA PCR wound swabs: sensitivity 97.6%, specificity 94.9%, NPV 98.4%. Supports rapid antibiotic de-escalation in stewardship programs.